CN104447929B - 一种合成3-羰基-4-雄烯-17β羧酸的方法 - Google Patents
一种合成3-羰基-4-雄烯-17β羧酸的方法 Download PDFInfo
- Publication number
- CN104447929B CN104447929B CN201410592089.5A CN201410592089A CN104447929B CN 104447929 B CN104447929 B CN 104447929B CN 201410592089 A CN201410592089 A CN 201410592089A CN 104447929 B CN104447929 B CN 104447929B
- Authority
- CN
- China
- Prior art keywords
- androstene
- carboxylic acid
- reaction
- hydroxyl
- carbonyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title claims abstract description 44
- YQACAXHKQZCEOI-UDCWSGSHSA-N 4-Androstene-3-oxo-17beta-carboxylic acid Natural products O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)C(O)=O)[C@@H]4[C@@H]3CCC2=C1 YQACAXHKQZCEOI-UDCWSGSHSA-N 0.000 title claims abstract description 32
- FOEOTLKUMCKCQW-YFWFAHHUSA-N C(=O)=C1C=C2CC[C@H]3[C@@H]4CC[C@@H]([C@@]4(C)CC[C@@H]3[C@]2(CC1)C)C(=O)O Chemical compound C(=O)=C1C=C2CC[C@H]3[C@@H]4CC[C@@H]([C@@]4(C)CC[C@@H]3[C@]2(CC1)C)C(=O)O FOEOTLKUMCKCQW-YFWFAHHUSA-N 0.000 title claims abstract description 32
- 230000002194 synthesizing effect Effects 0.000 title claims abstract description 5
- 238000006243 chemical reaction Methods 0.000 claims abstract description 49
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims abstract description 29
- 238000007254 oxidation reaction Methods 0.000 claims abstract description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 15
- 239000003054 catalyst Substances 0.000 claims abstract description 14
- 239000002253 acid Substances 0.000 claims abstract description 13
- 230000008569 process Effects 0.000 claims abstract description 8
- 238000010992 reflux Methods 0.000 claims abstract description 8
- 230000000630 rising effect Effects 0.000 claims abstract description 6
- 239000000243 solution Substances 0.000 claims abstract description 6
- 230000005945 translocation Effects 0.000 claims abstract description 6
- 230000009471 action Effects 0.000 claims abstract description 5
- 239000007864 aqueous solution Substances 0.000 claims abstract description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 16
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 16
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 9
- 239000005708 Sodium hypochlorite Substances 0.000 claims description 9
- 230000003647 oxidation Effects 0.000 claims description 9
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 claims description 9
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 6
- 239000001117 sulphuric acid Substances 0.000 claims description 6
- 235000011149 sulphuric acid Nutrition 0.000 claims description 6
- 238000001816 cooling Methods 0.000 claims description 4
- 239000001301 oxygen Substances 0.000 claims description 3
- 229910052760 oxygen Inorganic materials 0.000 claims description 3
- 229910052783 alkali metal Inorganic materials 0.000 claims description 2
- 150000001340 alkali metals Chemical class 0.000 claims description 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 claims description 2
- 150000001342 alkaline earth metals Chemical class 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 claims description 2
- 239000000047 product Substances 0.000 abstract description 22
- 238000010189 synthetic method Methods 0.000 abstract description 12
- 239000012065 filter cake Substances 0.000 abstract description 6
- 230000007613 environmental effect Effects 0.000 abstract description 5
- 238000005265 energy consumption Methods 0.000 abstract description 4
- 238000012805 post-processing Methods 0.000 abstract description 4
- 230000007935 neutral effect Effects 0.000 abstract description 3
- 239000002699 waste material Substances 0.000 abstract description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 15
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 230000015572 biosynthetic process Effects 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- MWUXSHHQAYIFBG-UHFFFAOYSA-N nitrogen oxide Inorganic materials O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 6
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 6
- 238000003786 synthesis reaction Methods 0.000 description 6
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical group O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 230000035943 smell Effects 0.000 description 4
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 4
- 230000002159 abnormal effect Effects 0.000 description 3
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- GDOPTJXRTPNYNR-UHFFFAOYSA-N methyl-cyclopentane Natural products CC1CCCC1 GDOPTJXRTPNYNR-UHFFFAOYSA-N 0.000 description 3
- 238000004080 punching Methods 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 0 C[C@]1(CCC(C2)=*)C2=CCC(C2CC[C@@]3C4*C4)C1CCC23C1=CC1 Chemical compound C[C@]1(CCC(C2)=*)C2=CCC(C2CC[C@@]3C4*C4)C1CCC23C1=CC1 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- -1 carboxylate methyl ester Chemical class 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000032050 esterification Effects 0.000 description 2
- 238000005886 esterification reaction Methods 0.000 description 2
- OUUQCZGPVNCOIJ-UHFFFAOYSA-N hydroperoxyl Chemical compound O[O] OUUQCZGPVNCOIJ-UHFFFAOYSA-N 0.000 description 2
- WQYVRQLZKVEZGA-UHFFFAOYSA-N hypochlorite Chemical compound Cl[O-] WQYVRQLZKVEZGA-UHFFFAOYSA-N 0.000 description 2
- QWPPOHNGKGFGJK-UHFFFAOYSA-N hypochlorous acid Chemical compound ClO QWPPOHNGKGFGJK-UHFFFAOYSA-N 0.000 description 2
- 231100000053 low toxicity Toxicity 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 238000007086 side reaction Methods 0.000 description 2
- 235000010265 sodium sulphite Nutrition 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 239000002351 wastewater Substances 0.000 description 2
- 201000004384 Alopecia Diseases 0.000 description 1
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 208000004403 Prostatic Hyperplasia Diseases 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- SMZOGRDCAXLAAR-UHFFFAOYSA-N aluminium isopropoxide Chemical compound [Al+3].CC(C)[O-].CC(C)[O-].CC(C)[O-] SMZOGRDCAXLAAR-UHFFFAOYSA-N 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 229960004199 dutasteride Drugs 0.000 description 1
- JWJOTENAMICLJG-QWBYCMEYSA-N dutasteride Chemical compound O=C([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)N[C@@H]4CC3)C)CC[C@@]21C)NC1=CC(C(F)(F)F)=CC=C1C(F)(F)F JWJOTENAMICLJG-QWBYCMEYSA-N 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229960004039 finasteride Drugs 0.000 description 1
- DBEPLOCGEIEOCV-WSBQPABSSA-N finasteride Chemical compound N([C@@H]1CC2)C(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H](C(=O)NC(C)(C)C)[C@@]2(C)CC1 DBEPLOCGEIEOCV-WSBQPABSSA-N 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000017105 transposition Effects 0.000 description 1
- 238000007039 two-step reaction Methods 0.000 description 1
- 238000009834 vaporization Methods 0.000 description 1
- 230000008016 vaporization Effects 0.000 description 1
- 239000002912 waste gas Substances 0.000 description 1
- 238000004065 wastewater treatment Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
- C07J3/005—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom the carbon atom being part of a carboxylic function
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Steroid Compounds (AREA)
Abstract
Description
Claims (17)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410592089.5A CN104447929B (zh) | 2014-10-28 | 2014-10-28 | 一种合成3-羰基-4-雄烯-17β羧酸的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410592089.5A CN104447929B (zh) | 2014-10-28 | 2014-10-28 | 一种合成3-羰基-4-雄烯-17β羧酸的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104447929A CN104447929A (zh) | 2015-03-25 |
CN104447929B true CN104447929B (zh) | 2016-06-29 |
Family
ID=52894738
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410592089.5A Active CN104447929B (zh) | 2014-10-28 | 2014-10-28 | 一种合成3-羰基-4-雄烯-17β羧酸的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104447929B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3875464A1 (en) * | 2020-03-06 | 2021-09-08 | F.I.S.- Fabbrica Italiana Sintetici S.p.A. | Process for the purification of etiocholenic acid |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2480632A (en) * | 2010-05-25 | 2011-11-30 | Kythera Biopharmaceuticals Inc | Preparation of 12-keto and 12-alpha-hydroxy steroids |
CN101948495B (zh) * | 2010-10-19 | 2012-07-04 | 浙江仙琚制药股份有限公司 | 化合物19-去甲基-4-雄甾烯-3,17-二酮的制备方法 |
CN104098639A (zh) * | 2014-08-06 | 2014-10-15 | 赵云现 | 17β-羧基-4-雄烯-3-酮的制备方法 |
-
2014
- 2014-10-28 CN CN201410592089.5A patent/CN104447929B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN104447929A (zh) | 2015-03-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102923663A (zh) | 一种从pta废水中回收溴的方法 | |
CN105712874A (zh) | 醇酯化法处理含异丁酸盐废水的方法 | |
CN102584820B (zh) | 一种5-溴-7-氮杂吲哚的制备方法 | |
JP2008280305A (ja) | フルオロカルボン酸エステルの製造方法 | |
CN103012026A (zh) | 一种溴代反应方法 | |
CN104447929B (zh) | 一种合成3-羰基-4-雄烯-17β羧酸的方法 | |
CN106748712A (zh) | 七氟丁酸及其衍生物的制备方法 | |
CN109810159A (zh) | 一种能从鸭胆汁中提高别胆酸收率的方法 | |
CN105330545B (zh) | 以氯化锡为催化剂回收三嗪环环合母液渣子中草酸的方法 | |
CN102020542B (zh) | 2-金刚烷酮的生产方法 | |
CN107501059B (zh) | 一种绿色环保的4-(4’-烷基环己基)环己酮的合成方法 | |
CN106349069A (zh) | 一种对羟基苯甲酸甲酯的制备方法 | |
CN101921190B (zh) | 生产2-甲基-4-氯苯氧乙酸的酯类的方法 | |
JP2885386B2 (ja) | 金属塩錯体 | |
CN114539103A (zh) | 2-二氟乙氧基-6-三氟甲基苯磺酰氯的合成方法 | |
CN104628559B (zh) | 臭氧氧化法制备卤代乙酸及其酯 | |
CN112479260A (zh) | 一种氧化石墨烯生产过程中废盐资源化利用的方法 | |
CN109796416A (zh) | 一种2-乙酰基吡嗪的合成方法 | |
CN101759554A (zh) | 一种处理和利用酒石酸氢钾母液的方法 | |
CN103752125A (zh) | 一种氯化亚砜氯化反应尾气处理的新方法 | |
CN105646297B (zh) | 一种生产贝利司他中间体的工艺方法 | |
CN107935900B (zh) | 一种三甲基氯化锍的制备方法 | |
CN109399674B (zh) | 一种从格氏反应废水及母液中提取溴镁化合物的方法 | |
CN108863792B (zh) | 一种异香茅烯的综合利用方法 | |
JP4500983B2 (ja) | 6−アルコキシ−2−ナフタレンチオールおよびその製造方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: 422900 Xinshao Economic Development Zone, Shaoyang Province, Xing Road, economic development zone, Hunan Applicant after: HUNAN KEREY PHARMACEUTICAL Co.,Ltd. Address before: 422900 Xinshao Economic Development Zone, Shaoyang Province, Xing Road, economic development zone, Hunan Applicant before: HUNAN KEREY BIOTECHNOLOGY Co.,Ltd. |
|
COR | Change of bibliographic data | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A method for synthesis of 3-carbonyl-4-androstene-17 b - carboxylic acid Effective date of registration: 20200928 Granted publication date: 20160629 Pledgee: China Co. truction Bank Corp Xinshao branch Pledgor: HUNAN KEREY PHARMACEUTICAL Co.,Ltd. Registration number: Y2020980006554 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20230131 Granted publication date: 20160629 Pledgee: China Co. truction Bank Corp Xinshao branch Pledgor: HUNAN KEREY PHARMACEUTICAL Co.,Ltd. Registration number: Y2020980006554 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A synthesis of 3-carbonyl-4-androsten-17 b Carboxylic acid method Granted publication date: 20160629 Pledgee: Industrial and Commercial Bank of China Limited Shaoyang Beita Branch Pledgor: HUNAN KEREY PHARMACEUTICAL Co.,Ltd. Registration number: Y2024980006163 |